HIV Epidemiology
The Latest
Trans Women Are Increasingly A Focus of HIV Programs, But What About their Cisgender Male Partners?
This population is under-represented in HIV data, and few prevention or treatment interventions exist to support them. A new meta-analysis hopes to paint a picture of what's needed.
The HIV Workforce Is in Trouble. Here Are Three Solutions to Address the Shortage of Providers.
If everyone living with HIV gets into care, do we have enough providers to support them? HIV doctors are proposing policy changes to address the workforce shortage.
Strong Peer Networks in Prison Boost Overall Health, Study Finds
But other research links prisons themselves to mental health challenges and infectious disease outbreaks.
This Week in HIV Research: My Achy-Breaky Heart
Sep. 5, 2019: An extra decade of "heart age"; stop grouping trans women with MSM; women often have anal cancer precursor lesions; hep C treatment success doesn't equal more risk behavior.
Trends in Deaths Among People With Hepatitis C Virus in British Columbia
A new study puts numbers to increasingly divergent trends in liver-related deaths vs. injection-related deaths in recent years, highlighting both the success of modern HCV treatment and the devastating effects of the opioid crisis.
The First In-Human Chlamydia Vaccine Trial Shows Positive Immune Response
A chlamydia infection makes HIV acquisition more likely.
This Week in HIV Research: Sex, Drugs, and Broken Bones
Aug. 8, 2019: Casual sex partners increase among U.S. MSM; why some MSM undervalue PrEP; proteinuria prevalence and fracture risk; cannabis, cocaine, and inflammation in people living with HIV.
The State of Cure Research for HIV and Hepatitis B: Similarities and Differences
Steven Deeks, M.D., talks about the medical community's hopes, inspirations, and unanswered questions regarding research for an HIV cure.
Experts Flummoxed By Conflicting New Data on STIs, HIV, and Long-Term Contraception in Sub-Saharan Africa
ECHO trial results and follow-up studies find unexpectedly low rates of some STIs among users of certain long-term hormonal contraceptives. They also find high HIV rates (unrelated to the contraceptives) that suggest considerable value for PrEP integration.
Large Scale HIV Vaccine Trial Announced, But PrEP May Challenge Enrollment
Will potential study participants choose a vaccine trial over getting access to PrEP?